Table 4.
Odds ratios of adverse events to treatment by infusion rate and presenting blood paracetamol
All vomiting | All anaphylactoid | ||||||||
---|---|---|---|---|---|---|---|---|---|
Events / n | OR | 95% CI | P | Events / n | OR | 95% CI | P | ||
Infusion rate1 | |||||||||
All patients (n = 8353) | 15 min | 73/321 | 1 | – | – | 29/321 | 1 | – | – |
1 h | 107/514 | 0.85 | 0.61, 1.20 | 0.368 | 55/514 | 1.22 | 0.75, 1.98 | 0.414 | |
<100 mg l−1 patients (n = 495) | 15 min | 46/185 | 1 | – | – | 26/185 | 1 | – | – |
1 h | 56/310 | 0.67 | 0.43, 1.05 | 0.084 | 47/310 | 1.10 | 0.66, 1.86 | 0.707 | |
>100 mg l−1 patients (n = 340) | 15 min | 27/136 | 1 | – | – | 3/136 | 1 | – | – |
1 h | 51/204 | 1.19 | 0.69, 2.04 | 0.527 | 8/204 | 2.15 | 0.54, 8.55 | 0.256 | |
Paracetamol concentration2 | |||||||||
All patients (n = 8353) | >100 | 78/340 | 1.09 | 0.78, 1.53 | 0.618 | 11/340 | 0.19 | 0.10, 0.37 | <0.001 |
<=100 | 102/495 | 1 | – | – | 73/495 | 1 | – | – | |
15 min infusion (n = 321) | >100 | 27/136 | 0.77 | 0.45, 1.33 | 0.354 | 3/136 | 0.14 | 0.04, 0.48 | <0.001 |
<=100 | 46/185 | 1 | – | – | 26/185 | 1 | – | – | |
1 h infusion (n = 514) | >100 | 51/204 | 1.37 | 0.88, 2.12 | 0.163 | 8/204 | 0.21 | 0.10, 0.47 | <0.001 |
<=100 | 56/310 | 1 | – | – | 47/310 | 1 | – | – | |
Age4 | |||||||||
All patients (n = 8353) | <35 | 111/412 | 1 | – | – | 45/423 | 1 | – | – |
>=35 | 69/413 | 0.58 | 0.42, 0.82 | 0.002 | 39/414 | 0.82 | 0.51, 1.30 | 0.391 | |
Gender5 | |||||||||
All patients (n = 8353) | Female | 125/507 | 1 | – | – | 51/507 | 1 | – | – |
Male | 55/328 | 0.66 | 0.46, 0.95 | 0.025 | 33/328 | 0.91 | 0.60, 1.51 | 0.688 |
1. Controlling for age, gender and presenting paracetamol concentration. 2. Controlling for age, gender and infusion rate. 3. one patient who had no data on blood paracetamol concentration was excluded. 4. Controlling for gender, infusion rate and presenting paracetamol concentration. 5. Controlling for gender, infusion rate and presenting blood paracetamol concentration.